Surgical treatment of impending paradoxical embolization associated with pulmonary embolism in a patient with heterozygosis of factor V Leiden

J Cardiovasc Med (Hagerstown). 2013 Oct;14(10):745-7. doi: 10.2459/JCM.0b013e32833893f9.

Abstract

We report an unusual case of impending paradoxical embolization in a 69-year-old woman heterozygote carrier of factor V Leiden mutation. The patient presented to the emergency room with the clinical scenario of massive pulmonary embolism. Serial echocardiographic examinations revealed a large thrombus in the right atrium floating via a patent foramen ovale into the left atrium. Anticoagulation therapy was started. After 72 h, due to the unresolved thrombus, the patient underwent surgical treatment consisting of complete excision of the thrombus, closure of the foramen ovale, and pulmonary embolectomy. No in-hospital complications were noted. At 1-year follow-up, the patient is doing well on long-term anticoagulation treatment free of thromboembolic events.

Publication types

  • Case Reports

MeSH terms

  • Activated Protein C Resistance / complications
  • Activated Protein C Resistance / diagnosis
  • Activated Protein C Resistance / genetics*
  • Aged
  • Anticoagulants / therapeutic use
  • Echocardiography, Transesophageal
  • Embolectomy*
  • Embolism, Paradoxical / diagnosis
  • Embolism, Paradoxical / etiology
  • Embolism, Paradoxical / surgery*
  • Factor V / genetics*
  • Female
  • Foramen Ovale, Patent / complications
  • Foramen Ovale, Patent / diagnosis
  • Heterozygote*
  • Humans
  • Mutation*
  • Pulmonary Embolism / diagnosis
  • Pulmonary Embolism / etiology
  • Pulmonary Embolism / surgery*
  • Thrombectomy*
  • Thrombosis / diagnosis
  • Thrombosis / etiology
  • Thrombosis / surgery*
  • Tomography, X-Ray Computed
  • Treatment Outcome

Substances

  • Anticoagulants
  • factor V Leiden
  • Factor V

Supplementary concepts

  • Thrombophilia due to Activated Protein C Resistance